As Joe Rogan told it, President Donald Trump jumped at the chance to facilitate regulatory approval of ibogaine and other psychedelics that have shown promise as psychotherapeutic catalysts. After the hugely popular, politically eclectic podcaster texted the president information about ibogaine, Rogan recalled, Trump replied: "Sounds great. Do you want FDA approval? Let's do it."
Rogan, who endorsed Trump in the 2024 election, told that story on April 18 as Trump signed an executive order instructing the Food and Drug Administration (FDA) to accelerate the review process for "appropriate psychedelic drugs," including ibogaine, and provide "at least $50 million from existing funds" to state programs investigating their potential. The FDA also is supposed to collaborate with the Department of Veterans Affairs on clinical trials.
